Floatz logo

Risperdal

Neuroinflammation

Hasanuddin UniversityPhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Neuroinflammation cohort.

Asset / SponsorPhaseRating
Dfn-15
Stony Brook University
Phase 4BB
Rvp-001
Reveal Pharmaceuticals Inc.
Phase 2B
Ashwagandha
Hasanuddin University
Phase 2B
Pmpbb3
Chang Gung Memorial Hospital
Phase 2CCC
HUMAN IMMUNOGLOBULINS
National Institute of Neurological Disorders and Stroke (NINDS)
Phase 2CCC
THK-5351
Chang Gung Memorial Hospital
Phase 2CCC
BLOOD, WHOLE
Vrije Universiteit Brussel
D
Arestin
University of Cincinnati
Phase 1NR

Same molecule, other indications

Risperdal is also rated in:

major depressive disorderDormant
BBB
Indicative ·
78 / 100
View asset →
psychotic disorderDormant
BBB
Indicative ·
77 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →